Product Description
Tranexamic acid is used to treat heavy menstrual bleeding in women. This medicine may be used by teenage females, but is not intended for use before the start of menstruation. Tranexamic acid is an antifibrinolytic agent. It works by blocking the breakdown of blood clots, which prevents bleeding. (Sourced from: https://www.mayoclinic.org/drugs-supplements/tranexamic-acid-oral-route/description/drg-20073517)
Mechanisms of Action: Fibrinolysis Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Intravenous,Topical,Oral
FDA Designation: None *
Approval Status: Approved
Approved Countries: Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam
Approved Indications: Injuries/wounds Unspecified
Known Adverse Events: Migraine Disorders | Abdominal Pain | Back Pain | Headache | Pain Unspecified | Anemia | Muscle Cramp | Musculoskeletal Pain
Company: Ferring
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: Australia, Belgium, Canada, China, Croatia, Denmark, Germany, Hungary, New Zealand, Nigeria, Pakistan, Qatar, Romania, Spain, Tanzania, United States, Unknown Location, Zambia
Active Clinical Trial Count: 17
Highest Development Phases
Phase 3: Acute Respiratory Distress Syndrome|Anaphylaxis|Anemia|Blood Coagulation Disorders|Brain Death|Brain Hemorrhage, Traumatic|Cardiac Arrest|Central Cord Syndrome|Coma|Heart Failure, Acute|Heart Failure, Chronic|Heart Failure, Systolic|Hematoma, Subdural|Hematoma, Subdural, Chronic|Hemostatic Disorders|Hip Fracture|Hypotension|Injuries/wounds Unspecified|Melanoma|Pregnancy Outcomes|Ranula|Respiratory Insufficiency|Sarcoma|Sepsis|Severe Acute Respiratory Syndrome|Total Knee Arthroplasty
Phase 2: Stroke